InvestorsHub Logo

rayank

05/21/15 9:30 AM

#10976 RE: doogdilinger #10974

"We are thrilled with the FDA’s positive acknowledgement, which enables us to accelerate the development and commercialization of our abuse deterrent Rexista™ Oxycodone XR product candidate," stated Dr. Isa Odidi, CEO and co-founder of Intellipharmaceutics. "The avoidance of a Phase III trial eliminates a significant financial hurdle. More importantly, it shortens the development timeline and potential time to market."

hogfan2

05/21/15 9:41 AM

#10989 RE: doogdilinger #10974

Agreed thought that was a positive omen when I saw that yesterday...my 20 yr old made his first stock purchase yesterday...1000 shares of IPCI...I probably have him hooked...lol